These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37827827)

  • 1. Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!
    Šťastná D; Seňavová J; Andělová M; Menkyová I; Pšenička O; Horáková D
    Vnitr Lek; 2023; 69(5):294-298. PubMed ID: 37827827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.
    Hauer L; Perneczky J; Sellner J
    J Neurol; 2021 Nov; 268(11):4066-4077. PubMed ID: 32719975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidities at multiple sclerosis diagnosis.
    Fromont A; Binquet C; Rollot F; Despalins R; Weill A; Clerc L; Bonithon-Kopp C; Moreau T
    J Neurol; 2013 Oct; 260(10):2629-37. PubMed ID: 23907437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular comorbidities in the onset and progression of multiple sclerosis.
    Tettey P; Simpson S; Taylor BV; van der Mei IA
    J Neurol Sci; 2014 Dec; 347(1-2):23-33. PubMed ID: 25454639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders.
    Konen FF; Möhn N; Witte T; Schefzyk M; Wiestler M; Lovric S; Hufendiek K; Schwenkenbecher P; Sühs KW; Friese MA; Klotz L; Pul R; Pawlitzki M; Hagin D; Kleinschnitz C; Meuth SG; Skripuletz T
    Autoimmun Rev; 2023 May; 22(5):103312. PubMed ID: 36924922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comorbidities in multiple sclerosis and their influence on the choice of treatment].
    Barboza A; Sinay V; Alonso R; Carnero-Contentti E; Hryb J; Silva B; Tavolini D; Ysrraelit MC; Correale J
    Rev Neurol; 2024 Mar; 78(6):157-170. PubMed ID: 38482703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland.
    Kapica-Topczewska K; Tarasiuk J; Chorąży M; Czarnowska A; Brola W; Szczepański M; Kochanowicz J; Kułakowska A
    Mult Scler Relat Disord; 2020 Jun; 41():102051. PubMed ID: 32197130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
    Zhang T; Tremlett H; Leung S; Zhu F; Kingwell E; Fisk JD; Bhan V; Campbell TL; Stadnyk K; Yu BN; Marrie RA;
    Neurology; 2016 Apr; 86(14):1287-1295. PubMed ID: 26944268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data.
    Maric GD; Pekmezovic TD; Mesaros ST; Tamas OS; Ivanovic JB; Martinovic VN; Andabaka MM; Jovanovic AL; Veselinovic ND; Kisic-Tepavcevic DB; Drulovic JS
    Neurol Sci; 2021 May; 42(5):1887-1893. PubMed ID: 32964347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis and aging: comorbidity and treatment challenges.
    Ostolaza A; Corroza J; Ayuso T
    Mult Scler Relat Disord; 2021 May; 50():102815. PubMed ID: 33581613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis is associated with higher comorbidity and health care resource use: A population-based, case-control study in a western Mediterranean region.
    Cárdenas-Robledo S; Otero-Romero S; Passarell-Bacardit MA; Carbonell-Mirabent P; Sastre-Garriga J; Montalban X; Tintoré M
    Eur J Neurol; 2021 Dec; 28(12):4124-4134. PubMed ID: 34293826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and migraine: Links, management and implications.
    Mrabet S; Wafa M; Giovannoni G
    Mult Scler Relat Disord; 2022 Dec; 68():104152. PubMed ID: 36058193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable.
    Conway DS; Sullivan AB; Rensel M
    Neurol Clin; 2024 Feb; 42(1):229-253. PubMed ID: 37980117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary tract infection in patients with multiple sclerosis: An overview.
    Medeiros Junior WLG; Demore CC; Mazaro LP; de Souza MFN; Parolin LF; Melo LH; Junior CRW; Gonçalves MVM
    Mult Scler Relat Disord; 2020 Nov; 46():102462. PubMed ID: 32890816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study.
    Lorefice L; Fenu G; Pitzalis R; Scalas G; Frau J; Coghe G; Musu L; Sechi V; Barracciu MA; Marrosu MG; Cocco E
    J Neurol; 2018 May; 265(5):1096-1101. PubMed ID: 29508133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
    Tettey P; Siejka D; Simpson S; Taylor B; Blizzard L; Ponsonby AL; Dwyer T; van der Mei I
    Neuroepidemiology; 2016; 46(2):106-13. PubMed ID: 26784322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.
    Thormann A; Magyari M; Koch-Henriksen N; Laursen B; Sørensen PS
    J Neurol; 2016 Dec; 263(12):2484-2493. PubMed ID: 27699465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans.
    Ozminkowski RJ; Marder WD; Hawkins K; Wang S; Stallings SC; Finkelstein SN; Sinskey AJ; Wierz D
    Clin Ther; 2004 Aug; 26(8):1341-54. PubMed ID: 15476915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study.
    Laroni A; Signori A; Maniscalco GT; Lanzillo R; Russo CV; Binello E; Lo Fermo S; Repice A; Annovazzi P; Bonavita S; Clerico M; Baroncini D; Prosperini L; La Gioia S; Rossi S; Cocco E; Frau J; Torri Clerici V; Signoriello E; Sartori A; Zarbo IR; Rasia S; Cordioli C; Cerqua R; Di Sapio A; Lavorgna L; Pontecorvo S; Barrilà C; Saccà F; Frigeni B; Esposito S; Ippolito D; Gallo F; Sormani MP;
    Neurology; 2017 Nov; 89(22):2222-2229. PubMed ID: 29093064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the prevalence of cognition and mental health among multiple sclerosis patients: A population-based cross-sectional study.
    Khader HA; Emran B; Sulaimi MA; Abdulhadi DA; Obaidli KA; Deai AA; Albatineh AN
    Mult Scler Relat Disord; 2019 Nov; 36():101391. PubMed ID: 31557677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.